(2021). Effectiveness of rosuvastatin plus colchicine, emtricitabine/tenofovir and combinations thereof in hospitalized patients with COVID-19: A pragmatic, open-label randomized trial.
Chicago Style (17th ed.) CitationEffectiveness of Rosuvastatin Plus Colchicine, Emtricitabine/tenofovir and Combinations Thereof in Hospitalized Patients with COVID-19: A Pragmatic, Open-label Randomized Trial. 2021.
MLA (8th ed.) CitationEffectiveness of Rosuvastatin Plus Colchicine, Emtricitabine/tenofovir and Combinations Thereof in Hospitalized Patients with COVID-19: A Pragmatic, Open-label Randomized Trial. 2021.
Warning: These citations may not always be 100% accurate.